Nuvation Bio Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q3 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Nuvation Bio Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q3 2020 to Q4 2023.
  • Nuvation Bio Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $100M, a 18% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $100M +$15.4M +18% Dec 31, 2023 10-K 2024-02-29
Q4 2022 $85.1M +$30.7M +56.3% Dec 31, 2022 10-K 2024-02-29
Q4 2021 $54.5M +$32.7M +150% Dec 31, 2021 10-K 2023-03-15
Q4 2020 $21.7M Dec 31, 2020 10-K 2022-02-28
Q3 2020 $154K Sep 30, 2020 10-Q 2020-11-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.